Richard Robert E. 4
4 · Lyra Therapeutics, Inc. · Filed Feb 15, 2022
Insider Transaction Report
Form 4
Richard Robert E.
SVP of R&D
Transactions
- Award
Stock Option
2022-02-12+35,000→ 35,000 totalExercise: $4.78Exp: 2032-02-11→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following February 12, 2022.